ID   SAP_HUMAN               Reviewed;         524 AA.
AC   P07602; P07292; P15793; P78538; P78541; P78546; P78547; P78558;
AC   Q53Y86; Q6IBQ6; Q92739; Q92740; Q92741; Q92742;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 2.
DT   21-MAR-2012, entry version 161.
DE   RecName: Full=Proactivator polypeptide;
DE   Contains:
DE     RecName: Full=Saposin-A;
DE     AltName: Full=Protein A;
DE   Contains:
DE     RecName: Full=Saposin-B-Val;
DE   Contains:
DE     RecName: Full=Saposin-B;
DE     AltName: Full=Cerebroside sulfate activator;
DE              Short=CSAct;
DE     AltName: Full=Dispersin;
DE     AltName: Full=Sphingolipid activator protein 1;
DE              Short=SAP-1;
DE     AltName: Full=Sulfatide/GM1 activator;
DE   Contains:
DE     RecName: Full=Saposin-C;
DE     AltName: Full=A1 activator;
DE     AltName: Full=Co-beta-glucosidase;
DE     AltName: Full=Glucosylceramidase activator;
DE     AltName: Full=Sphingolipid activator protein 2;
DE              Short=SAP-2;
DE   Contains:
DE     RecName: Full=Saposin-D;
DE     AltName: Full=Component C;
DE     AltName: Full=Protein C;
DE   Flags: Precursor;
GN   Name=PSAP; Synonyms=GLBA, SAP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   MEDLINE=90129043; PubMed=2515150; DOI=10.1016/0888-7543(89)90014-1;
RA   Rorman E.G., Grabowski G.A.;
RT   "Molecular cloning of a human co-beta-glucosidase cDNA: evidence that
RT   four sphingolipid hydrolase activator proteins are encoded by single
RT   genes in humans and rats.";
RL   Genomics 5:486-492(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=89255151; PubMed=2498298;
RA   Nakano T., Sandhoff K., Stuemper J., Christomanou H., Suzuki K.;
RT   "Structure of full-length cDNA coding for sulfatide activator, a Co-
RT   beta-glucosidase and two other homologous proteins: two alternate
RT   forms of the sulfatide activator.";
RL   J. Biochem. 105:152-154(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SAP-MU-0).
RC   TISSUE=Brain, Eye, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-524.
RX   MEDLINE=88321660; PubMed=2842863; DOI=10.1126/science.2842863;
RA   O'Brien J.S., Kretz K.A., Dewji N., Wenger D.A., Esch F.,
RA   Fluharty A.L.;
RT   "Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by
RT   same genetic locus.";
RL   Science 241:1098-1101(1988).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 14-524.
RX   MEDLINE=92307663; PubMed=1612590; DOI=10.1016/0888-7543(92)90247-P;
RA   Rorman E.G., Scheinker V., Grabowski G.A.;
RT   "Structure and evolution of the human prosaposin chromosomal gene.";
RL   Genomics 13:312-318(1992).
RN   [10]
RP   PROTEIN SEQUENCE OF 17-24; 165-172; 180-189 AND 298-302.
RX   MEDLINE=93311991; PubMed=8323276; DOI=10.1006/abbi.1993.1328;
RA   Hiraiwa M., O'Brien J.S., Kishimoto Y., Galdzicka M., Fluharty A.L.,
RA   Ginns E.I., Martin B.M.;
RT   "Isolation, characterization, and proteolysis of human prosaposin, the
RT   precursor of saposins (sphingolipid activator proteins).";
RL   Arch. Biochem. Biophys. 304:110-116(1993).
RN   [11]
RP   PROTEIN SEQUENCE OF 17-26.
RC   TISSUE=Milk;
RX   MEDLINE=92068206; PubMed=1958198; DOI=10.1016/S0006-291X(05)81415-9;
RA   Kondoh K., Hineno T., Sano A., Kakimoto Y.;
RT   "Isolation and characterization of prosaposin from human milk.";
RL   Biochem. Biophys. Res. Commun. 181:286-292(1991).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 59-125 AND 304-513.
RC   TISSUE=Brain;
RX   MEDLINE=91192146; PubMed=2013321; DOI=10.1016/0014-5793(91)80308-P;
RA   Holtschmidt H., Sandhoff K., Fuerst W., Kwon H.Y., Schnabel D.,
RA   Suzuki K.;
RT   "The organization of the gene for the human cerebroside sulfate
RT   activator protein.";
RL   FEBS Lett. 280:267-270(1991).
RN   [13]
RP   PROTEIN SEQUENCE OF 60-142.
RX   MEDLINE=89240739; PubMed=2717620; DOI=10.1073/pnas.86.9.3389;
RA   Morimoto S., Martin B.M., Yamamoto Y., Kretz K.A., O'Brien J.S.,
RA   Kishimoto Y.;
RT   "Saposin A: second cerebrosidase activator protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:3389-3393(1989).
RN   [14]
RP   PROTEIN SEQUENCE OF 62-84 AND 410-431.
RX   MEDLINE=93380576; PubMed=8370464; DOI=10.1016/0014-5793(93)80908-D;
RA   Tyynela J., Palmer D.N., Baumann M., Haltia M.;
RT   "Storage of saposins A and D in infantile neuronal ceroid-
RT   lipofuscinosis.";
RL   FEBS Lett. 330:8-12(1993).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 164-524.
RX   MEDLINE=88068647; PubMed=2825202; DOI=10.1073/pnas.84.23.8652;
RA   Dewji N.N., Wenger D.A., O'Brien J.S.;
RT   "Nucleotide sequence of cloned cDNA for human sphingolipid activator
RT   protein 1 precursor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:8652-8656(1987).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 195-263.
RX   MEDLINE=86130593; PubMed=2868718; DOI=10.1016/S0006-291X(86)80518-6;
RA   Dewji N.N., Wenger D.A., Fujibayashi S., Donoviel M., Esch F.,
RA   Hill F., O'Brien J.S.;
RT   "Molecular cloning of the sphingolipid activator protein-1 (SAP-1),
RT   the sulfatide sulfatase activator.";
RL   Biochem. Biophys. Res. Commun. 134:989-994(1986).
RN   [17]
RP   PROTEIN SEQUENCE OF 195-274.
RX   MEDLINE=89207118; PubMed=3242555;
RA   Kleinschmidt T., Christomanou H., Braunitzer G.;
RT   "Complete amino-acid sequence of the naturally occurring A2 activator
RT   protein for enzymic sphingomyelin degradation: identity to the
RT   sulfatide activator protein (SAP-1).";
RL   Biol. Chem. Hoppe-Seyler 369:1361-1365(1988).
RN   [18]
RP   PROTEIN SEQUENCE OF 195-274.
RC   TISSUE=Kidney;
RX   MEDLINE=91006165; PubMed=2209618;
RX   DOI=10.1111/j.1432-1033.1990.tb19280.x;
RA   Furst W., Schubert J., Machleidt W., Meyer H.E., Sandhoff K.;
RT   "The complete amino-acid sequences of human ganglioside GM2 activator
RT   protein and cerebroside sulfate activator protein.";
RL   Eur. J. Biochem. 192:709-714(1990).
RN   [19]
RP   PROTEIN SEQUENCE OF 311-390.
RX   MEDLINE=88163077; PubMed=3442600;
RA   Kleinschmidt T., Christomanou H., Braunitzer G.;
RT   "Complete amino-acid sequence and carbohydrate content of the
RT   naturally occurring glucosylceramide activator protein (A1 activator)
RT   absent from a new human Gaucher disease variant.";
RL   Biol. Chem. Hoppe-Seyler 368:1571-1578(1987).
RN   [20]
RP   PROTEIN SEQUENCE OF 405-484.
RX   MEDLINE=89025876; PubMed=2845979; DOI=10.1016/S0006-291X(88)80855-6;
RA   Morimoto S., Martin B.M., Kishimoto Y., O'Brien J.S.;
RT   "Saposin D: a sphingomyelinase activator.";
RL   Biochem. Biophys. Res. Commun. 156:403-410(1988).
RN   [21]
RP   PROTEIN SEQUENCE OF 407-484.
RX   MEDLINE=89000190; PubMed=3048308;
RA   Furst W., Machleidt W., Sandhoff K.;
RT   "The precursor of sulfatide activator protein is processed to three
RT   different proteins.";
RL   Biol. Chem. Hoppe-Seyler 369:317-328(1988).
RN   [22]
RP   PARTIAL PROTEIN SEQUENCE (SAPOSIN-B), AND STRUCTURE OF CARBOHYDRATES.
RC   TISSUE=Urine;
RX   MEDLINE=20032116; PubMed=10562467; DOI=10.1006/mgme.1999.2900;
RA   Fluharty A.L., Lombardo C., Louis A., Stevens R.L., Whitelegge J.P.,
RA   Waring A.J., To T., Fluharty C.B., Faull K.F.;
RT   "Preparation of the cerebroside sulfate activator (CSAct or saposin B)
RT   from human urine.";
RL   Mol. Genet. Metab. 68:391-403(1999).
RN   [23]
RP   DISULFIDE BONDS IN SAPOSINS-B AND C, AND MASS SPECTROMETRY.
RX   MEDLINE=95247790; PubMed=7730378; DOI=10.1074/jbc.270.17.9953;
RA   Vaccaro A.M., Salvioli R., Barca A., Tatti M., Ciaffoni F., Maras B.,
RA   Siciliano R., Zappacosta F., Amoresano A., Pucci P.;
RT   "Structural analysis of saposin C and B. Complete localization of
RT   disulfide bridges.";
RL   J. Biol. Chem. 270:9953-9960(1995).
RN   [24]
RP   STRUCTURE OF CARBOHYDRATE ON ASN-215.
RX   MEDLINE=21110404; PubMed=11180632;
RX   DOI=10.1002/1096-9888(200012)35:12<1416::AID-JMS75>3.0.CO;2-K;
RA   Faull K.F., Johnson J., Kim M.J., To T., Whitelegge J.P.,
RA   Stevens R.L., Fluharty C.B., Fluharty A.L.;
RT   "Structure of the asparagine-linked sugar chains of porcine kidney and
RT   human urine cerebroside sulfate activator protein.";
RL   J. Mass Spectrom. 35:1416-1424(2000).
RN   [25]
RP   DISULFIDE BONDS IN SAPOSIN-D.
RX   MEDLINE=99337688; PubMed=10406958;
RX   DOI=10.1046/j.1432-1327.1999.00521.x;
RA   Tatti M., Salvioli R., Ciaffoni F., Pucci P., Andolfo A.,
RA   Amoresano A., Vaccaro A.M.;
RT   "Structural and membrane-binding properties of saposin D.";
RL   Eur. J. Biochem. 263:486-494(1999).
RN   [26]
RP   DISULFIDE BONDS IN SAPOSIN-B.
RX   MEDLINE=22398398; PubMed=12510003; DOI=10.1016/S1046-5928(02)00597-1;
RA   Ahn V.E., Faull K.F., Whitelegge J.P., Higginson J., Fluharty A.L.,
RA   Prive G.G.;
RT   "Expression, purification, crystallization, and preliminary X-ray
RT   analysis of recombinant human saposin B.";
RL   Protein Expr. Purif. 27:186-193(2003).
RN   [27]
RP   MASS SPECTROMETRY.
RC   TISSUE=Urine;
RX   MEDLINE=99441404; PubMed=10510427;
RX   DOI=10.1002/(SICI)1096-9888(199910)34:10<1040::AID-JMS863>3.0.CO;2-X;
RA   Faull K.F., Whitelegge J.P., Higginson J., To T., Johnson J.,
RA   Krutchinsky A.N., Standing K.G., Waring A.J., Stevens R.L.,
RA   Fluharty C.B., Fluharty A.L.;
RT   "Cerebroside sulfate activator protein (Saposin B): chromatographic
RT   and electrospray mass spectrometric properties.";
RL   J. Mass Spectrom. 34:1040-1054(1999).
RN   [28]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-80; ASN-101; ASN-332 AND
RP   ASN-426, AND MASS SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 195-273, AND MUTAGENESIS OF
RP   ILE-240.
RX   MEDLINE=22406333; PubMed=12518053; DOI=10.1073/pnas.0136947100;
RA   Ahn V.E., Faull K.F., Whitelegge J.P., Fluharty A.L., Prive G.G.;
RT   "Crystal structure of saposin B reveals a dimeric shell for lipid
RT   binding.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:38-43(2003).
RN   [30]
RP   REVIEW ON MLD-SAPB VARIANTS.
RX   MEDLINE=95170731; PubMed=7866401; DOI=10.1002/humu.1380040402;
RA   Gieselmann V., Zlotogora J., Harris A., Wenger D.A., Morris C.P.;
RT   "Molecular genetics of metachromatic leukodystrophy.";
RL   Hum. Mutat. 4:233-242(1994).
RN   [31]
RP   VARIANT MLD-SAPB ILE-217.
RX   MEDLINE=90147748; PubMed=2302219; DOI=10.1016/0006-291X(90)90912-7;
RA   Rafi M.A., Zhang X.-L., Degala G., Wenger D.A.;
RT   "Detection of a point mutation in sphingolipid activator protein-1
RT   mRNA in patients with a variant form of metachromatic
RT   leukodystrophy.";
RL   Biochem. Biophys. Res. Commun. 166:1017-1023(1990).
RN   [32]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT MLD-SAPB ILE-217.
RX   MEDLINE=90207231; PubMed=2320574; DOI=10.1073/pnas.87.7.2541;
RA   Kretz K.A., Carson G.S., Morimoto S., Kishimoto Y., Fluharty A.L.,
RA   O'Brien J.S.;
RT   "Characterization of a mutation in a family with saposin B deficiency:
RT   a glycosylation site defect.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2541-2544(1990).
RN   [33]
RP   VARIANT MLD-SAPB SER-241, NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE
RP   SPLICING.
RX   MEDLINE=91210267; PubMed=2019586;
RA   Holtschmidt H., Sandhoff K., Kwon H.Y., Harzer K., Nakano T.,
RA   Suzuki K.;
RT   "Sulfatide activator protein. Alternative splicing that generates
RT   three mRNAs and a newly found mutation responsible for a clinical
RT   disease.";
RL   J. Biol. Chem. 266:7556-7560(1991).
RN   [34]
RP   INVOLVEMENT IN CSAPD.
RX   PubMed=1371116;
RA   Schnabel D., Schroder M., Furst W., Klein A., Hurwitz R., Zenk T.,
RA   Weber J., Harzer K., Paton B.C., Poulos A., Suzuki K., Sandhoff K.;
RT   "Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is
RT   caused by a mutation in the initiation codon of their common gene.";
RL   J. Biol. Chem. 267:3312-3315(1992).
RN   [35]
RP   VARIANT AGD PHE-388.
RX   MEDLINE=91285107; PubMed=2060627; DOI=10.1016/0014-5793(91)80760-Z;
RA   Schnabel D., Schroeder M., Sandhoff K.;
RT   "Mutation in the sphingolipid activator protein 2 in a patient with a
RT   variant of Gaucher disease.";
RL   FEBS Lett. 284:57-59(1991).
RN   [36]
RP   VARIANT MLD-SAPB LYS-215.
RX   PubMed=10196694; DOI=10.1038/sj.ejhg.5200266;
RA   Regis S., Filocamo M., Corsolini F., Caroli F., Keulemans J.L.M.,
RA   van Diggelen O.P., Gatti R.;
RT   "An Asn > Lys substitution in saposin B involving a conserved amino
RT   acidic residue and leading to the loss of the single N-glycosylation
RT   site in a patient with metachromatic leukodystrophy and normal
RT   arylsulphatase A activity.";
RL   Eur. J. Hum. Genet. 7:125-130(1999).
RN   [37]
RP   VARIANT MLD-SAPB HIS-215, AND CHARACTERIZATION OF VARIANT MLD-SAPB
RP   HIS-215.
RX   PubMed=10682309; DOI=10.1023/A:1005603014401;
RA   Wrobe D., Henseler M., Huettler S., Pascual Pascual S.I., Chabas A.,
RA   Sandhoff K.;
RT   "A non-glycosylated and functionally deficient mutant (N215H) of the
RT   sphingolipid activator protein B (SAP-B) in a novel case of
RT   metachromatic leukodystrophy (MLD).";
RL   J. Inherit. Metab. Dis. 23:63-76(2000).
RN   [38]
RP   INVOLVEMENT IN CSAPD.
RX   PubMed=11309366; DOI=10.1093/hmg/10.9.927;
RA   Hulkova H., Cervenkova M., Ledvinova J., Tochackova M., Hrebicek M.,
RA   Poupetova H., Befekadu A., Berna L., Paton B.C., Harzer K., Boor A.,
RA   Smid F., Elleder M.;
RT   "A novel mutation in the coding region of the prosaposin gene leads to
RT   a complete deficiency of prosaposin and saposins, and is associated
RT   with a complex sphingolipidosis dominated by lactosylceramide
RT   accumulation.";
RL   Hum. Mol. Genet. 10:927-940(2001).
RN   [39]
RP   VARIANT AKRD VAL-70 DEL.
RX   PubMed=15773042; DOI=10.1016/j.ymgme.2004.10.004;
RA   Spiegel R., Bach G., Sury V., Mengistu G., Meidan B., Shalev S.,
RA   Shneor Y., Mandel H., Zeigler M.;
RT   "A mutation in the saposin A coding region of the prosaposin gene in
RT   an infant presenting as Krabbe disease: first report of saposin A
RT   deficiency in humans.";
RL   Mol. Genet. Metab. 84:160-166(2005).
RN   [40]
RP   VARIANT AGD PRO-349.
RX   PubMed=17919309; DOI=10.1111/j.1399-0004.2007.00899.x;
RA   Tylki-Szymanska A., Czartoryska B., Vanier M.T., Poorthuis B.J.,
RA   Groener J.A., Lugowska A., Millat G., Vaccaro A.M., Jurkiewicz E.;
RT   "Non-neuronopathic Gaucher disease due to saposin C deficiency.";
RL   Clin. Genet. 72:538-542(2007).
CC   -!- FUNCTION: The lysosomal degradation of sphingolipids takes place
CC       by the sequential action of specific hydrolases. Some of these
CC       enzymes require specific low-molecular mass, non-enzymic proteins:
CC       the sphingolipids activator proteins (coproteins).
CC   -!- FUNCTION: Saposin-A and saposin-C stimulate the hydrolysis of
CC       glucosylceramide by beta-glucosylceramidase (EC 3.2.1.45) and
CC       galactosylceramide by beta-galactosylceramidase (EC 3.2.1.46).
CC       Saposin-C apparently acts by combining with the enzyme and acidic
CC       lipid to form an activated complex, rather than by solubilizing
CC       the substrate.
CC   -!- FUNCTION: Saposin-B stimulates the hydrolysis of galacto-
CC       cerebroside sulfate by arylsulfatase A (EC 3.1.6.8), GM1
CC       gangliosides by beta-galactosidase (EC 3.2.1.23) and
CC       globotriaosylceramide by alpha-galactosidase A (EC 3.2.1.22).
CC       Saposin-B forms a solubilizing complex with the substrates of the
CC       sphingolipid hydrolases.
CC   -!- FUNCTION: Saposin-D is a specific sphingomyelin phosphodiesterase
CC       activator (EC 3.1.4.12).
CC   -!- SUBUNIT: Saposin-B is a homodimer.
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist;
CC       Name=Sap-mu-0;
CC         IsoId=P07602-1; Sequence=Displayed;
CC       Name=Sap-mu-6;
CC         IsoId=P07602-2; Sequence=VSP_006014;
CC       Name=Sap-mu-9;
CC         IsoId=P07602-3; Sequence=VSP_006015;
CC   -!- PTM: This precursor is proteolytically processed to 4 small
CC       peptides, which are similar to each other and are sphingolipid
CC       hydrolase activator proteins.
CC   -!- PTM: N-linked glycans show a high degree of microheterogeneity.
CC   -!- PTM: The one residue extended Saposin-B-Val is only found in 5% of
CC       the chains.
CC   -!- DISEASE: Defects in PSAP are the cause of combined saposin
CC       deficiency (CSAPD) [MIM:611721]; also known as prosaposin
CC       deficiency. CSAPD is due to absence of all saposins, leading to a
CC       fatal storage disorder with hepatosplenomegaly and severe
CC       neurological involvement.
CC   -!- DISEASE: Defects in PSAP saposin-B region are the cause of
CC       leukodystrophy metachromatic due to saposin-B deficiency (MLD-
CC       SAPB) [MIM:249900]. MLD-SAPB is an atypical form of metachromatic
CC       leukodystrophy. It is characterized by tissue accumulation of
CC       cerebroside-3-sulfate, demyelination, periventricular white matter
CC       abnormalities, peripheral neuropathy. Additional neurological
CC       features include dysarthria, ataxic gait, psychomotr regression,
CC       seizures, cognitive decline and spastic quadriparesis.
CC   -!- DISEASE: Defects in PSAP saposin-C region are the cause of
CC       atypical Gaucher disease (AGD) [MIM:610539]. Affected individuals
CC       have marked glucosylceramide accumulation in the spleen without
CC       having a deficiency of glucosylceramide-beta glucosidase
CC       characteristic of classic Gaucher disease, a lysosomal storage
CC       disorder.
CC   -!- DISEASE: Defects in PSAP saposin-A region are the cause of
CC       atypical Krabbe disease (AKRD) [MIM:611722]. AKRD is a disorder of
CC       galactosylceramide metabolism. AKRD features include progressive
CC       encephalopathy and abnormal myelination in the cerebral white
CC       matter resembling Krabbe disease.
CC   -!- DISEASE: Note=Defects in PSAP saposin-D region are found in a
CC       variant of Tay-Sachs disease (GM2-gangliosidosis).
CC   -!- MISCELLANEOUS: Saposin-B co-purifies with 1 molecule of
CC       phosphatidylethanolamine.
CC   -!- SIMILARITY: Contains 2 saposin A-type domains.
CC   -!- SIMILARITY: Contains 4 saposin B-type domains.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PSAPID42980ch10q22.html";
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/PSAP";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03077; AAA52560.1; -; mRNA.
DR   EMBL; D00422; BAA00321.1; -; mRNA.
DR   EMBL; BT006849; AAP35495.1; -; mRNA.
DR   EMBL; CR456746; CAG33027.1; -; mRNA.
DR   EMBL; AL731541; CAI40837.1; -; Genomic_DNA.
DR   EMBL; AC073370; CAI40837.1; JOINED; Genomic_DNA.
DR   EMBL; CH471083; EAW54437.1; -; Genomic_DNA.
DR   EMBL; BC001503; AAH01503.1; -; mRNA.
DR   EMBL; BC004275; AAH04275.1; -; mRNA.
DR   EMBL; BC007612; AAH07612.1; -; mRNA.
DR   EMBL; M86181; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X57107; CAA40391.1; -; Genomic_DNA.
DR   EMBL; X57108; CAA40392.1; -; Genomic_DNA.
DR   EMBL; M12710; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; J03015; AAB59494.1; -; mRNA.
DR   EMBL; M32221; AAA60303.1; -; mRNA.
DR   EMBL; M60257; AAA36595.1; -; mRNA.
DR   EMBL; M60258; AAA36596.1; -; mRNA.
DR   EMBL; M60255; AAA36594.1; -; mRNA.
DR   IPI; IPI00012503; -.
DR   IPI; IPI00219825; -.
DR   IPI; IPI00744835; -.
DR   PIR; JX0061; SAHUP.
DR   RefSeq; NP_001035930.1; NM_001042465.1.
DR   RefSeq; NP_001035931.1; NM_001042466.1.
DR   RefSeq; NP_002769.1; NM_002778.2.
DR   UniGene; Hs.523004; -.
DR   PDB; 1M12; NMR; -; A=311-390.
DR   PDB; 1N69; X-ray; 2.20 A; A/B/C=195-273.
DR   PDB; 1SN6; NMR; -; A=311-390.
DR   PDB; 2DOB; X-ray; 2.00 A; A=60-140.
DR   PDB; 2GTG; X-ray; 2.40 A; A=311-391.
DR   PDB; 2QYP; X-ray; 2.45 A; A/B=311-392.
DR   PDB; 2R0R; X-ray; 2.50 A; A/B=407-484.
DR   PDB; 2R1Q; X-ray; 2.50 A; A=407-484.
DR   PDB; 2RB3; X-ray; 2.10 A; A/B/C/D=407-484.
DR   PDB; 2Z9A; X-ray; 2.50 A; A/B=311-389.
DR   PDB; 3BQP; X-ray; 1.30 A; A/B=405-484.
DR   PDB; 3BQQ; X-ray; 2.00 A; A/B/C/D=405-484.
DR   PDBsum; 1M12; -.
DR   PDBsum; 1N69; -.
DR   PDBsum; 1SN6; -.
DR   PDBsum; 2DOB; -.
DR   PDBsum; 2GTG; -.
DR   PDBsum; 2QYP; -.
DR   PDBsum; 2R0R; -.
DR   PDBsum; 2R1Q; -.
DR   PDBsum; 2RB3; -.
DR   PDBsum; 2Z9A; -.
DR   PDBsum; 3BQP; -.
DR   PDBsum; 3BQQ; -.
DR   ProteinModelPortal; P07602; -.
DR   SMR; P07602; 34-140, 195-272, 312-484.
DR   DIP; DIP-29803N; -.
DR   IntAct; P07602; 9.
DR   MINT; MINT-1193270; -.
DR   STRING; P07602; -.
DR   TCDB; 1.C.35.2.1; amoebapore family.
DR   GlycoSuiteDB; P07602; -.
DR   DMDM; 134218; -.
DR   PRIDE; P07602; -.
DR   DNASU; 5660; -.
DR   Ensembl; ENST00000394936; ENSP00000378394; ENSG00000197746.
DR   Ensembl; ENST00000404083; ENSP00000384385; ENSG00000197746.
DR   GeneID; 5660; -.
DR   KEGG; hsa:5660; -.
DR   UCSC; uc001jsm.1; human.
DR   CTD; 5660; -.
DR   GeneCards; GC10M073576; -.
DR   HGNC; HGNC:9498; PSAP.
DR   HPA; CAB004647; -.
DR   HPA; HPA004426; -.
DR   MIM; 176801; gene.
DR   MIM; 249900; phenotype.
DR   MIM; 610539; phenotype.
DR   MIM; 611721; phenotype.
DR   MIM; 611722; phenotype.
DR   neXtProt; NX_P07602; -.
DR   Orphanet; 139406; Encephalopathy due to prosaposin deficiency.
DR   Orphanet; 355; Gaucher disease.
DR   Orphanet; 512; Metachromatic leukodystrophy.
DR   PharmGKB; PA33845; -.
DR   eggNOG; NOG269151; -.
DR   GeneTree; ENSGT00530000063434; -.
DR   HOVERGEN; HBG002617; -.
DR   KO; K12382; -.
DR   PhylomeDB; P07602; -.
DR   Reactome; REACT_111217; Metabolism.
DR   Reactome; REACT_604; Hemostasis.
DR   NextBio; 21992; -.
DR   ArrayExpress; P07602; -.
DR   Bgee; Q53Y86; -.
DR   CleanEx; HS_PSAP; -.
DR   Genevestigator; P07602; -.
DR   GermOnline; ENSG00000197746; Homo sapiens.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0016021; C:integral to membrane; TAS:ProtInc.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005765; C:lysosomal membrane; TAS:Reactome.
DR   GO; GO:0008047; F:enzyme activator activity; TAS:ProtInc.
DR   GO; GO:0008289; F:lipid binding; TAS:ProtInc.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   GO; GO:0006869; P:lipid transport; TAS:ProtInc.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   InterPro; IPR003119; SapA.
DR   InterPro; IPR007856; SapB_1.
DR   InterPro; IPR008138; SapB_2.
DR   InterPro; IPR008373; Saposin.
DR   InterPro; IPR011001; Saposin-like.
DR   InterPro; IPR021165; Saposin_chordata.
DR   InterPro; IPR008139; SaposinB.
DR   Gene3D; G3DSA:1.10.225.10; Saposin_like; 4.
DR   Pfam; PF02199; SapA; 2.
DR   Pfam; PF05184; SapB_1; 4.
DR   Pfam; PF03489; SapB_2; 4.
DR   PIRSF; PIRSF002431; Saposin; 1.
DR   PRINTS; PR01797; SAPOSIN.
DR   SMART; SM00162; SAPA; 2.
DR   SMART; SM00741; SapB; 4.
DR   SUPFAM; SSF47862; Saposin_like; 4.
DR   PROSITE; PS51110; SAP_A; 2.
DR   PROSITE; PS50015; SAP_B; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Gangliosidosis; Gaucher disease; Glycoprotein; Leukodystrophy;
KW   Lipid metabolism; Lysosome; Metachromatic leukodystrophy;
KW   Reference proteome; Repeat; Signal; Sphingolipid metabolism.
FT   SIGNAL        1     16
FT   PROPEP       17     58
FT                                /FTId=PRO_0000031616.
FT   CHAIN        60    142       Saposin-A.
FT                                /FTId=PRO_0000031617.
FT   PROPEP      144    194
FT                                /FTId=PRO_0000031618.
FT   CHAIN       195    274       Saposin-B-Val.
FT                                /FTId=PRO_0000031619.
FT   CHAIN       195    273       Saposin-B.
FT                                /FTId=PRO_0000031620.
FT   PROPEP      276    309
FT                                /FTId=PRO_0000031621.
FT   CHAIN       311    391       Saposin-C.
FT                                /FTId=PRO_0000031622.
FT   PROPEP      393    403
FT                                /FTId=PRO_0000031623.
FT   CHAIN       405    486       Saposin-D.
FT                                /FTId=PRO_0000031624.
FT   PROPEP      488    524
FT                                /FTId=PRO_0000031625.
FT   DOMAIN       18     58       Saposin A-type 1.
FT   DOMAIN       59    142       Saposin B-type 1.
FT   DOMAIN      194    275       Saposin B-type 2.
FT   DOMAIN      311    392       Saposin B-type 3.
FT   DOMAIN      405    486       Saposin B-type 4.
FT   DOMAIN      488    524       Saposin A-type 2.
FT   SITE        215    215       Not glycosylated; in variant MLD-SAPB
FT                                Ile-217.
FT   CARBOHYD     80     80       N-linked (GlcNAc...).
FT   CARBOHYD    101    101       N-linked (GlcNAc...).
FT   CARBOHYD    215    215       N-linked (GlcNAc...) (complex).
FT                                /FTId=CAR_000176.
FT   CARBOHYD    332    332       N-linked (GlcNAc...).
FT   CARBOHYD    426    426       N-linked (GlcNAc...).
FT   DISULFID     63    138
FT   DISULFID     66    132
FT   DISULFID     94    106
FT   DISULFID    198    271
FT   DISULFID    201    265
FT   DISULFID    230    241
FT   DISULFID    315    388
FT   DISULFID    318    382
FT   DISULFID    346    357
FT   DISULFID    409    482
FT   DISULFID    412    476
FT   DISULFID    440    451
FT   VAR_SEQ     259    259       M -> MDQ (in isoform Sap-mu-6).
FT                                /FTId=VSP_006014.
FT   VAR_SEQ     260    260       Q -> QDQQ (in isoform Sap-mu-9).
FT                                /FTId=VSP_006015.
FT   VARIANT      70     70       Missing (in AKRD).
FT                                /FTId=VAR_042440.
FT   VARIANT     215    215       N -> H (in MLD-SAPB; reduces the
FT                                intracellular activity of the protein
FT                                significantly).
FT                                /FTId=VAR_031823.
FT   VARIANT     215    215       N -> K (in MLD-SAPB).
FT                                /FTId=VAR_031899.
FT   VARIANT     217    217       T -> I (in MLD-SAPB; juvenile; affects
FT                                glycosylation at N-215).
FT                                /FTId=VAR_006943.
FT   VARIANT     241    241       C -> S (in MLD-SAPB; severe;
FT                                dbSNP:rs1130793).
FT                                /FTId=VAR_006944.
FT   VARIANT     349    349       L -> P (in AGD).
FT                                /FTId=VAR_042441.
FT   VARIANT     388    388       C -> F (in AGD).
FT                                /FTId=VAR_006945.
FT   MUTAGEN     240    240       I->C: Strongly decreases stimulation of
FT                                cerebroside sulfate hydrolysis.
FT   CONFLICT    369    369       L -> P (in Ref. 4; CAG33027).
FT   HELIX        61     78
FT   HELIX        83     93
FT   HELIX        94     96
FT   STRAND       97     99
FT   HELIX       100    120
FT   HELIX       128    134
FT   HELIX       196    214
FT   HELIX       218    229
FT   HELIX       230    233
FT   HELIX       237    256
FT   HELIX       261    267
FT   HELIX       314    330
FT   HELIX       335    345
FT   HELIX       351    373
FT   HELIX       378    384
FT   HELIX       409    422
FT   HELIX       429    439
FT   HELIX       440    442
FT   HELIX       445    447
FT   HELIX       448    466
FT   HELIX       472    478
SQ   SEQUENCE   524 AA;  58113 MW;  71977F7A8C9E1533 CRC64;
     MYALFLLASL LGAALAGPVL GLKECTRGSA VWCQNVKTAS DCGAVKHCLQ TVWNKPTVKS
     LPCDICKDVV TAAGDMLKDN ATEEEILVYL EKTCDWLPKP NMSASCKEIV DSYLPVILDI
     IKGEMSRPGE VCSALNLCES LQKHLAELNH QKQLESNKIP ELDMTEVVAP FMANIPLLLY
     PQDGPRSKPQ PKDNGDVCQD CIQMVTDIQT AVRTNSTFVQ ALVEHVKEEC DRLGPGMADI
     CKNYISQYSE IAIQMMMHMQ PKEICALVGF CDEVKEMPMQ TLVPAKVASK NVIPALELVE
     PIKKHEVPAK SDVYCEVCEF LVKEVTKLID NNKTEKEILD AFDKMCSKLP KSLSEECQEV
     VDTYGSSILS ILLEEVSPEL VCSMLHLCSG TRLPALTVHV TQPKDGGFCE VCKKLVGYLD
     RNLEKNSTKQ EILAALEKGC SFLPDPYQKQ CDQFVAEYEP VLIEILVEVM DPSFVCLKIG
     ACPSAHKPLL GTEKCIWGPS YWCQNTETAA QCNAVEHCKR HVWN
//
